EVERSANA continues to redefine the future of pharmaceutical commercialization with its newly launched AI Accelerator—a dedicated center of excellence designed to embed artificial intelligence across every touchpoint of the life sciences value chain.
Spearheaded by Chief Innovation Officer Faruk Capan and Chief Digital Officer Scott Snyder, the initiative aims to “pharmatize AI”—applying cutting-edge technology in ways that are deeply relevant to pharma. From accelerating patient identification to delivering hyper-personalized engagement for healthcare professionals and patients, the Accelerator is built to unlock transformative value.
Capan and Snyder recently spoke with Pharmaceutical Executive Magazine about the initiative and how it addresses critical gaps in the industry. “Innovation is embedded in EVERSANA’s DNA, and we have been an early mover in applying AI in the pharma space,” said Faruk Capan in the interview. “This initiative brings together our top AI practitioners with like-minded partners, platforms, and services to unlock new value for clients and patients.”
Read the full article on Pharmaceutical Commerce including comments from both Capan and Snyder here.
Connect With An Expert!
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…